Universal Health Services Inc (UHS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $11.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Universal Health Services Inc (UHS) Financials: Revenue, Profit and Cash Flow
Universal Health Services reported revenue of $17.36B for the fiscal year ended Dec 31, 2025, up 9.7% from the year before. That year, net income was $1.51B with a net margin of 8.7%, operating cash flow was $1.86B and free cash flow was $849.25M. The quarter ended Sep 30, 2026 had revenue of $4.73B and net income of $313.33M.
Revenue and Margins
The operating margin was 11.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $9.77B, a compound annual rate of 6.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $17.36B | +9.7% | 53.4% | 11.5% | 8.7% |
| Dec 2024 | $15.83B | +10.8% | 52.5% | 10.6% | 7.3% |
| Dec 2023 | $14.28B | +6.6% | 50.2% | 8.2% | 5.0% |
| Dec 2022 | $13.40B | +6.0% | 49.5% | 7.5% | 4.9% |
| Dec 2021 | $12.64B | +9.4% | 51.2% | 10.8% | 7.8% |
| Dec 2020 | $11.56B | +1.6% | 51.4% | 11.8% | 8.2% |
| Dec 2019 | $11.38B | +5.6% | 50.9% | 10.7% | 7.3% |
| Dec 2018 | $10.77B | +3.5% | 51.2% | 10.9% | 7.4% |
| Dec 2017 | $10.41B | +6.6% | 52.2% | 12.3% | 7.4% |
| Dec 2016 | $9.77B | N/A | 53.0% | 13.1% | 7.7% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 30.2% from the year before. In the quarter ended Sep 2026, net income fell 17.4% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B |
| Cost of revenue | $8.08B | $7.52B | $7.11B | $6.76B | $6.16B | $5.61B | $5.59B | $5.25B | $4.98B | $4.59B |
| Gross profit | $9.28B | $8.31B | $7.17B | $6.64B | $6.48B | $5.95B | $5.79B | $5.52B | $5.43B | $5.18B |
| Operating income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B |
| Net income | $1.51B | $1.16B | $719.31M | $656.98M | $987.63M | $952.79M | $827.54M | $797.88M | $771.31M | $747.17M |
| EBITDA | $2.75B | $2.27B | $1.72B | $1.58B | $1.91B | $1.87B | $1.72B | $1.64B | $1.73B | $1.70B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.73B | $4.64B | $4.50B | $4.49B | $4.50B | $4.28B | $4.10B | $4.11B | $3.96B | $3.91B | $3.84B | $3.70B |
| Gross profit | $2.52B | $2.50B | $2.41B | $2.44B | $2.42B | $2.27B | $2.15B | $2.21B | $2.05B | $2.05B | $2.00B | $1.90B |
| Operating income | $454.45M | $516.67M | $502.86M | $517.23M | $521.69M | $500.27M | $454.82M | $472.49M | $384.17M | $436.40M | $388.76M | $331.20M |
| Net income | $313.33M | $364.59M | $358.68M | $447.84M | $379.11M | $362.61M | $321.63M | $337.05M | $265.91M | $294.33M | $265.82M | $219.62M |
Balance Sheet
As of Dec 2025, total debt of $4.75B exceeded cash and equivalents by $4.61B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.53B | $14.47B | $13.97B | $13.49B | $13.09B | $13.48B | $11.67B | $11.27B | $10.76B | $10.32B |
| Current assets | $3.41B | $2.82B | $2.81B | $2.54B | $2.26B | $3.28B | $1.92B | $1.94B | $1.80B | $1.68B |
| Cash and equivalents | $137.80M | $125.98M | $119.44M | $102.82M | $115.30M | $1.22B | $61.27M | $105.22M | $74.42M | $33.75M |
| Total liabilities | $8.12B | $7.71B | $7.77B | $7.52B | $6.90B | $7.07B | $6.09B | $5.80B | $5.70B | $5.71B |
| Short-term debt | $748.16M | $40.06M | $126.69M | $81.45M | $48.41M | $332.00M | $87.55M | $63.45M | $545.62M | $105.89M |
| Long-term debt | $4.00B | $4.46B | $4.79B | $4.73B | $4.14B | $3.52B | $3.90B | $3.94B | $3.49B | $4.03B |
| Shareholder equity | $7.28B | $6.67B | $6.15B | $5.92B | $6.09B | $6.32B | $5.50B | $5.39B | $4.99B | $4.53B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $17.19B | $15.94B | $15.68B | $15.96B | $15.34B | $14.99B | $14.88B | $14.47B | $14.35B | $14.07B | $14.05B | $13.97B |
| Total liabilities | $9.44B | $8.28B | $8.08B | $8.55B | $8.05B | $7.84B | $7.99B | $7.71B | $7.67B | $7.52B | $7.74B | $7.77B |
| Cash and equivalents | $168.75M | $138.80M | $119.03M | $137.80M | $112.89M | $137.59M | $126.75M | $125.98M | $106.08M | $128.79M | $112.09M | $119.44M |
| Shareholder equity | $7.60B | $7.51B | $0 | $7.28B | $7.17B | $7.03B | $6.79B | $6.67B | $6.61B | $6.49B | $6.26B | $6.15B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 45.7% of operating cash flow. Dividends and share repurchases together came to 118.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.86B | $2.07B | $1.27B | $996.02M | $883.70M | $2.36B | $1.44B | $1.27B | $1.25B | $1.33B |
| Capital expenditures | $1.02B | $943.81M | $743.05M | $734.00M | $855.66M | $731.31M | $634.10M | $664.96M | $557.51M | $541.41M |
| Free cash flow | $849.25M | $1.12B | $524.74M | $262.02M | $28.04M | $1.63B | $804.37M | $609.78M | $690.08M | $792.43M |
| Dividends paid | $40.16M | $46.87M | $59.55M | $112.34M | $59.78M | $19.19M | $68.86M | $51.94M | $62.92M | $108.46M |
| Share repurchases | $967.95M | $670.75M | $547.36M | $832.92M | $1.22B | $206.72M | $770.50M | $397.43M | $364.40M | $353.38M |
| Investing cash flow | -$1.07B | -$911.11M | -$763.27M | -$647.30M | -$914.47M | -$802.56M | -$688.41M | -$747.25M | -$684.73M | -$1.16B |
| Financing cash flow | -$749.73M | -$1.14B | -$493.94M | -$318.40M | -$1.07B | -$384.86M | -$845.04M | -$492.20M | -$519.15M | -$171.17M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $636.56M | $443.30M | $401.63M | $574.69M | $380.68M | $548.98M | $360.05M | $658.44M | $332.98M | $679.28M | $396.41M | $452.43M |
| Capital expenditures | $214.94M | $227.63M | $217.16M | $281.22M | $228.89M | $266.01M | $239.03M | $245.94M | $247.93M | $241.39M | $208.54M | $206.39M |
| Free cash flow | $421.61M | $215.67M | $184.47M | $293.47M | $151.79M | $282.96M | $121.02M | $412.49M | $85.05M | $437.89M | $187.87M | $246.04M |
Frequently Asked Questions About UHS
What is Universal Health Services' annual revenue?
Universal Health Services reported revenue of $17.36B for the fiscal year ended Dec 31, 2025.
How fast is Universal Health Services' revenue growing?
Revenue was up 9.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.0%.
Is Universal Health Services profitable?
Yes. Universal Health Services reported net income of $1.51B for the fiscal year ended Dec 31, 2025, with a net margin of 8.7%.
How much free cash flow does UHS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.86B minus capital expenditures of $1.02B produced free cash flow of $849.25M.
How much debt does Universal Health Services have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $4.00B, short-term debt of $748.16M and cash and equivalents of $137.80M.
UHS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors